M Jane Ehrke
Affiliations: | State University of New York, Buffalo, Buffalo, NY, United States |
Area:
Molecular Biology, Cell Biology, Animal Physiology BiologyGoogle:
"M Ehrke"
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Ewens A, Luo L, Berleth E, et al. (2006) Doxorubicin plus interleukin-2 chemoimmunotherapy against breast cancer in mice. Cancer Research. 66: 5419-26 |
| Ujhazy P, Zaleskis G, Mihich E, et al. (2003) Doxorubicin induces specific immune functions and cytokine expression in peritoneal cells. Cancer Immunology, Immunotherapy : Cii. 52: 463-72 |
| Berleth ES, Masso-Welch PA, Kazim LA, et al. (2001) Expression, tissue distribution, and cellular localization of the antiapoptotic TIP-B1 protein. Journal of Leukocyte Biology. 69: 995-1005 |
| Henn AD, Berleth ES, Mihich E, et al. (2001) Changes in cytosolic and membrane TNF inhibitory protein-B1 (TIP-B1) levels associated with protection from TNF-induced cytotoxicity. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 15: 1315-7 |
| Mihich E, Berleth E, Henn A, et al. (2001) Modulation of tumor necrosis factor (TNFα) in cancer therapeutics European Journal of Cancer. 37: S148 |
| Berleth ES, Henn AD, Gurtoo HL, et al. (2000) A novel tumor necrosis factor-alpha inhibitory protein, TIP-B1. International Journal of Immunopharmacology. 22: 1137-42 |
| Ehrke MJ, Verstovsek S, Maccubbin DL, et al. (2000) Protective specific immunity induced by doxorubicin plus TNF-alpha combination treatment of EL4 lymphoma-bearing C57BL/6 mice. International Journal of Cancer. 87: 101-9 |
| Nadadur SS, Ehrke MJ, Gurtoo HL. (1999) A novel TNF-inducible message with putative growth suppressor function. Biochimica Et Biophysica Acta. 1489: 433-9 |
| Berleth ES, Nadadur S, Henn AD, et al. (1999) Identification, characterization, and cloning of TIP-B1, a novel protein inhibitor of tumor necrosis factor-induced lysis. Cancer Research. 59: 5497-506 |
| Ehrke MJ, Verstovsek S, Pocchiari SK, et al. (1998) Thymic anti-tumor effectors in mice cured of lymphoma by cyclophosphamide plus TNF-alpha therapy: phenotypic and functional characterization up to 20 months after initial tumor inoculation. International Journal of Cancer. 76: 579-86 |